Sonoma Pharmaceuticals announces pricing of public offering of units
Sonoma Pharmaceuticals announced the pricing of a "best efforts" public offering of units consisting of one share of common stock, together with one half of one warrant to purchase one share of common stock at an exercise price equal to $1 per whole share. The public offering price was $1 per unit. The offering is expected to close on or about November 21, 2018, subject to customary closing conditions. Certain investors, who would beneficially own, together with its affiliates and certain related parties, more than 4.99% of the outstanding common stock as a result of the public offering, can purchase series C convertible preferred stock convertible into shares of common stock, in lieu of purchasing common stock.